Wealth Enhancement Advisory Services LLC Acquires Shares of 2,482 Amedisys, Inc. (NASDAQ:AMED)

Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Amedisys, Inc. (NASDAQ:AMED) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 2,482 shares of the health services provider’s stock, valued at approximately $225,000.

A number of other hedge funds have also added to or reduced their stakes in AMED. Empowered Funds LLC purchased a new stake in shares of Amedisys in the 4th quarter worth about $318,000. Blue Trust Inc. grew its position in shares of Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock worth $34,000 after buying an additional 124 shares during the period. Rhumbline Advisers grew its position in shares of Amedisys by 1.6% in the 4th quarter. Rhumbline Advisers now owns 91,298 shares of the health services provider’s stock worth $8,289,000 after buying an additional 1,412 shares during the period. State of New Jersey Common Pension Fund D grew its position in shares of Amedisys by 14.6% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 23,324 shares of the health services provider’s stock worth $2,118,000 after buying an additional 2,967 shares during the period. Finally, Venturi Wealth Management LLC grew its position in shares of Amedisys by 397.4% in the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider’s stock worth $89,000 after buying an additional 779 shares during the period. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Stock Performance

Shares of Amedisys stock opened at $97.34 on Tuesday. The stock has a market cap of $3.19 billion, a price-to-earnings ratio of 38.63, a PEG ratio of 1.78 and a beta of 0.94. The firm’s 50-day moving average is $94.19 and its 200 day moving average is $91.97. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.13 by $0.12. The company had revenue of $594.78 million for the quarter, compared to analysts’ expectations of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Amedisys’s revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.03 EPS. Sell-side analysts anticipate that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AMED has been the topic of a number of recent research reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Amedisys in a research report on Wednesday, April 16th. Stephens reaffirmed an “equal weight” rating and issued a $101.00 target price on shares of Amedisys in a research report on Tuesday, March 4th. Finally, Wall Street Zen cut shares of Amedisys from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 24th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.